Flexion Therapeutics Hits New 1-Year Low at $13.37 (FLXN)
Flexion Therapeutics (NASDAQ:FLXN) hit a new 52-week low during trading on Wednesday , Analyst Ratings Network.com reports. The company traded as low as $13.37 and last traded at $13.60, with a volume of 27,958 shares trading hands. The stock had previously closed at $14.75.
A number of research firms have recently commented on FLXN. Analysts at Janney Montgomery Scott initiated coverage on shares of Flexion Therapeutics in a research note on Wednesday, March 19th. They set a “buy” rating and a $25.00 price target on the stock. Separately, analysts at Needham & Company LLC initiated coverage on shares of Flexion Therapeutics in a research note on Monday, March 10th. They set a “buy” rating on the stock. Finally, analysts at Wells Fargo & Co. initiated coverage on shares of Flexion Therapeutics in a research note on Monday, March 10th. They set an “outperform” rating on the stock.
The stock’s 50-day moving average is $17.39 and its 200-day moving average is $16.94. The company’s market cap is $211.8 million.
Flexion Therapeutics, Inc (NASDAQ:FLXN) is a specialty pharmaceutical company focused on the development and commercialization of injectable pain therapies.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.